These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16785106)

  • 1. Neurophysiological effects of botulinum toxin type A.
    Abbruzzese G; Berardelli A
    Neurotox Res; 2006 Apr; 9(2-3):109-14. PubMed ID: 16785106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological changes after intramuscular injection of botulinum toxin.
    Palomar FJ; Mir P
    Clin Neurophysiol; 2012 Jan; 123(1):54-60. PubMed ID: 22051548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
    Mazzocchio R; Caleo M
    Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.
    Raghunath A; Perez-Branguli F; Smith L; Dolly JO
    J Neurosci; 2008 Apr; 28(14):3683-8. PubMed ID: 18385326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of botulinum toxin on motor system excitability in patients with writer's cramp.
    Boroojerdi B; Cohen LG; Hallett M
    Neurology; 2003 Dec; 61(11):1546-50. PubMed ID: 14663040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle.
    Harrison AR; Berbos Z; Zaldivar RA; Anderson BC; Semmer M; Lee MS; McLoon LK
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):982-6. PubMed ID: 21087967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.
    Smith CP; Gangitano DA; Munoz A; Salas NA; Boone TB; Aoki KR; Francis J; Somogyi GT
    Neurochem Int; 2008 May; 52(6):1068-75. PubMed ID: 18187233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
    Cai BB; Francis J; Brin MF; Broide RS
    Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles.
    Ishikawa H; Mitsui Y; Yoshitomi T; Mashimo K; Aoki S; Mukuno K; Shimizu K
    Jpn J Ophthalmol; 2000; 44(2):106-9. PubMed ID: 10715374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin: mechanism of action].
    Bogucki A
    Neurol Neurochir Pol; 1998; 32 Suppl 1():23-33. PubMed ID: 9608550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A, brain and pain.
    Matak I; Lacković Z
    Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin type A and cholinergic system].
    Bach-Rojecky L; Relja M; Filipović B; Lacković Z
    Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats.
    Runfola M; Rossi S; Panunzi S; Spada PL; Gui D
    BMC Gastroenterol; 2003 Sep; 3():26. PubMed ID: 12964945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Central Effects of Botulinum Toxin in Dystonia and Spasticity.
    Hok P; Veverka T; Hluštík P; Nevrlý M; Kaňovský P
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.
    Matak I; Lacković Z; Relja M
    J Neural Transm (Vienna); 2016 Dec; 123(12):1415-1421. PubMed ID: 27586162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Applications of botulinum toxin in Neurology].
    Garcia-Ruiz PJ
    Med Clin (Barc); 2013 Jul; 141(1):33-6. PubMed ID: 23434466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs.
    Bittencourt MK; de Vasconcellos JP; Bittencourt MD; Malagó R; Bacellar M
    J Ocul Pharmacol Ther; 2013 May; 29(4):431-6. PubMed ID: 23323889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.